Literature DB >> 8398141

Developmental regulation of highly active alternatively spliced forms of agrin.

W Hoch1, M Ferns, J T Campanelli, Z W Hall, R H Scheller.   

Abstract

Agrin is an extracellular matrix protein involved in clustering acetylcholine receptors during development of the neuromuscular junction. We have previously shown that alternative splicing at three sites generates multiple forms of rat agrin and that a novel 8 amino acid insert is the most important in determining biological activity. In the present study we have examined the expression of agrin during development with particular emphasis on determining the tissue distribution of the splicing variants at each site. Our principal observation is that the variants containing the sequence most responsible for biological activity are expressed exclusively in neural tissue and that their expression is highly regulated during development. We also show that muscle expresses less active forms and that agrin immunoreactivity during synaptogenesis is initially not limited to synaptic sites, but becomes progressively restricted to the synapse as development proceeds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398141     DOI: 10.1016/0896-6273(93)90152-h

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  53 in total

1.  Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing.

Authors:  M Brudno; M S Gelfand; S Spengler; M Zorn; I Dubchak; J G Conboy
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

2.  Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

Authors:  J E Donahue; T M Berzin; M S Rafii; D J Glass; G D Yancopoulos; J R Fallon; E G Stopa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 3.  The role of agrin in synaptic development, plasticity and signaling in the central nervous system.

Authors:  Mathew P Daniels
Journal:  Neurochem Int       Date:  2012-03-05       Impact factor: 3.921

4.  Structural basis of agrin-LRP4-MuSK signaling.

Authors:  Yinong Zong; Bin Zhang; Shenyan Gu; Kwangkook Lee; Jie Zhou; Guorui Yao; Dwight Figueiredo; Kay Perry; Lin Mei; Rongsheng Jin
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

5.  Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface.

Authors:  J J O'Toole; K A Deyst; M A Bowe; M A Nastuk; B A McKechnie; J R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  AChR phosphorylation and aggregation induced by an agrin fragment that lacks the binding domain for alpha-dystroglycan.

Authors:  T Meier; M Gesemann; V Cavalli; M A Ruegg; B G Wallace
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

7.  Substrate-bound agrin induces expression of acetylcholine receptor epsilon-subunit gene in cultured mammalian muscle cells.

Authors:  G Jones; A Herczeg; M A Ruegg; M Lichtsteiner; S Kröger; H R Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

8.  Agrin induced morphological and structural changes in growth cones of cultured hippocampal neurons.

Authors:  R A Bergstrom; R C Sinjoanu; A Ferreira
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

9.  Specific agrin isoforms induce cAMP response element binding protein phosphorylation in hippocampal neurons.

Authors:  R R Ji; C M Böse; C Lesuisse; D Qiu; J C Huang; Q Zhang; F Rupp
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin.

Authors:  Jung Hae Yoon; Kumaran Chandrasekharan; Rui Xu; Matthew Glass; Neha Singhal; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2009-05-12       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.